Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hydrocortisone 1% ointment
1304000V0AABCBC
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 76,188 |
|
Betamethasone valerate 0.1% ointment
1304000F0AABABA
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 75,746 |
|
Mometasone 0.1% cream
1304000Y0AAAAAA
|
Mometasone furoate (Topical) | Mometasone furoate | Skin | 74,049 |
|
Benzoyl peroxide 5% / Clindamycin 1% gel
1306010Y0AAAAAA
|
Benzoyl peroxide/clindamycin phosphate | Benzoyl peroxide and clindamycin phosphate | Skin | 71,204 |
|
Terbinafine 1% cream
131002030AAAAAA
|
Terbinafine hydrochloride (Topical) | Terbinafine hydrochloride | Skin | 59,148 |
|
Balneum Plus cream
1302010U0BHAAAN
|
Balneum Plus | Urea | Skin | 59,119 |
|
Clobetasol 0.05% cream
1304000G0AAAAAA
|
Clobetasol propionate | Clobetasol propionate | Skin | 58,058 |
|
Betnovate 0.1% cream
1304000F0BBAAAA
|
Betnovate (Topical) | Betamethasone valerate | Skin | 55,708 |
|
Fucibet cream
1304000F0BCABCC
|
Fucibet | Betamethasone valerate | Skin | 55,000 |
|
Eumovate 0.05% cream
1304000H0BBAAAA
|
Eumovate (Topical) | Clobetasone butyrate | Skin | 52,707 |
|
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% oint
1305020D0AAAFAF
|
Calcipotriol | Calcipotriol | Skin | 51,722 |
|
Dermol 200 shower emollient
130201100BBAZAN
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 51,484 |
|
Betamethasone valerate 0.025% ointment
1304000F0AABBBB
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 50,979 |
|
Permethrin 5% cream
1310040Q0AAABAB
|
Permethrin | Permethrin | Skin | 50,861 |
|
Adapalene 0.1% / Benzoyl peroxide 2.5% gel
1306010Z0AAAAAA
|
Adapalene/benzoyl peroxide | Adapalene and benzoyl peroxide | Skin | 49,621 |
|
Tacrolimus 0.1% ointment
1305030C0AAAAAA
|
Tacrolimus (Topical) | Tacrolimus | Skin | 49,102 |
|
Dermovate 0.05% ointment
1304000G0BBABBA
|
Dermovate | Clobetasol propionate | Skin | 46,930 |
|
Fucidin H cream
1304000X0BHABCB
|
Fucidin H | Hydrocortisone acetate | Skin | 44,661 |
|
Amorolfine 5% medicated nail lacquer
1310020A0AAAAAA
|
Amorolfine hydrochloride | Amorolfine hydrochloride | Skin | 43,173 |
|
Betnovate 0.1% ointment
1304000F0BBAEBA
|
Betnovate (Topical) | Betamethasone valerate | Skin | 41,699 |
|
White soft paraffin 50% / Liquid paraffin 50% ointment
130201000AAA6A6
|
Generic compound emollients | Other emollient preparations | Skin | 40,194 |
|
Daktacort 2%/1% cream
1304000V0CGABCH
|
Daktacort | Hydrocortisone | Skin | 38,273 |
|
Fluorouracil 5% cream
1308010Y0AAAAAA
|
Fluorouracil (Sunscreen) | Fluorouracil (Sunscreen) | Skin | 38,234 |
|
Eumovate 0.05% ointment
1304000H0BBABBA
|
Eumovate (Topical) | Clobetasone butyrate | Skin | 38,126 |
|
Dermovate 0.05% cream
1304000G0BBAAAA
|
Dermovate | Clobetasol propionate | Skin | 36,280 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.